Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis

Annals of the Rheumatic Diseases

Volumn 70, Issue 4, 2011, Pages 646-652

  Rego Perez I ^a   Fernandez Moreno M ^a   Deberg, M ^b   Pertega S ^a   Fernandez Lopez C ^a   Oreiro, N ^a   Henrotin, Y ^b   Blanco, Francisco J ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; MITOCHONDRIAL DNA; MYELOPEROXIDASE; STROMELYSIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPLOTYPE; HETEROZYGOTE; HIP RADIOGRAPHY; HUMAN; IMAGE ANALYSIS; KELLGREN AND LAWRENCE SCORING; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SMOKING;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PEPTIDE HYDROLASES;

EID: 79952359481     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.133637     Document Type: Article

References (40)

1. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998;41:1343-55. (Pubitemid 28373113)
2. Ravaud P, Giraudeau B, Auleley GR, et al. Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis. Ann Rheum Dis 1998;57:624-9. (Pubitemid 28513142)
3. Blackburn WD Jr, Chivers S, Bernreuter W. Cartilage imaging in osteoarthritis. Semin Arthritis Rheum 1996;25:273-81. (Pubitemid 26078484)
4. Garnero P, Ayral X, Rousseau JC, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002;46:2613-24. (Pubitemid 36118924)
5. Garnero P, Piperno M, Gineyts E, et al. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001;60:619-26. (Pubitemid 32493990)
6. Christgau S, Garnero P, Fledelius C, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-15. (Pubitemid 32823562)
7. Vignon E, Garnero P, Delmas P, et al. Respect of Ethics and Excellence in Science (GREES): Osteoarthritis Section. Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthr Cartil 2001;9:289-93. (Pubitemid 32454771)
8. Terkeltaub R, Johnson K, Murphy A, et al. Invited review: the mitochondrion in osteoarthritis. Mitochondrion 2002;1:301-19. (Pubitemid 34272620)
9. Maneiro E, Martín MA, de Andres MC, et al. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum 2003;48:700-8. (Pubitemid 36302006)
10. Cillero-Pastor B, Caramés B, Lires-Deán M, et al. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum 2008;58:2409-19.
11. Merriwether DA, Clark AG, Ballinger SW, et al. The structure of human mitochondrial DNA variation. J Mol Evol 1991;33:543-55.
12. Torroni A, Huoponen K, Francalacci P, et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 1996;144:1835-50. (Pubitemid 26427929)
13. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39:359-407. (Pubitemid 43011120)
14. Niemi AK, Hervonen A, Hurme M, et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 2003;112:29-33. (Pubitemid 36869112)
15. Gómez-Durán A, Pacheu-Grau D, López-Gallardo E, et al. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 2010;19:3343-53.
16. Rego-Pérez I, Fernández-Moreno M, Fernández- López C, et al. Mitochondrial DNA haplogroups: role in the prevalence and severity of knee osteoarthritis. Arthritis Rheum 2008;58:2387-96.
17. Rego I, Fernández-Moreno M, Fernández-López C, et al. Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Ann Rheum Dis 2010;69:210-13.
18. Rego-Pérez I, Fernández-Moreno M, Deberg M, et al. Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Ann Rheum Dis 2010;69:910-7.
19. Henrotin Y, Kurz B. Antioxidant to treat osteoarthritis: dream or reality? Curr Drug Targets 2007;8:347-57.
20. Cillero-Pastor B, Rego-Pérez I, Lema B, et al. Mitochondrial respiratory dysfunction regulates the metalloproteinases expression in human normal chondrocytes in culture [abstract]. Arthritis Rheum 2009;60:S1295.
21. Deberg M, Dubuc JE, Labasse A, et al. One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement. Ann Rheum Dis 2008;67:168-74. (Pubitemid 351183304)
22. Rees MD, Hawkins CL, Davies MJ. Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates. Biochem J 2004;381(Pt 1):175-84. (Pubitemid 38932223)
23. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
24. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
25. Green MJ, Smith J, Gough A, et al. Serum MMP-3 and MMP-1 correlate with disease activity and predict progression of joint damage in early rheumatoid arthritis [abstract]. Arthritis Rheum 1999;42:S173.
26. Ishiguro N, Ito T, Ito H, et al. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum 1999;42:129-36. (Pubitemid 29042579)
27. Lohmander LS, Brandt KD, Mazzuca SA, et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum 2005;52:3160-7. (Pubitemid 41447098)
28. Naito K, Takahashi M, Kushida K, et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford) 1999;38:510-15. (Pubitemid 29504835)
29. Takahashi M, Naito K, Abe M, et al. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 2004;6:R208-12.
30. Keyszer G, Lambiri I, Nagel R, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999;26:251-8. (Pubitemid 29066724)
31. Manicourt DH, Fujimoto N, Obata K, et al. Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum 1994;37:1774-83. (Pubitemid 24371880)
32. Reboul P, Pelletier JP, Tardif G, et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996;97:2011-9. (Pubitemid 26143954)
33. Ruiz-Pesini E, Lapeña AC, Díez-Sánchez C, et al. Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet 2000;67:682-96. (Pubitemid 30659599)
34. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8. (Pubitemid 26060542)
35. Nagase H, Okada Y. Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. The Textbook of Rheumatology. Fifth edition. Philadelphia, PA: Saunders 1995:323-41.
36. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. The Textbook of Rheumatology. Fifth edition. Philadelphia, PA: Saunders 1996:851-97.
37. Aigner T, Zien A, Gehrsitz A, et al. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001;44:2777-89. (Pubitemid 34016197)
38. Mazières B, Garnero P, Guéguen A, et al. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis 2006;65:354-9. (Pubitemid 43268225)
39. Dejica VM, Mort JS, Laverty S, et al. Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage. Am J Pathol 2008;173:161-9. (Pubitemid 351947964)
40. Martínez-Redondo D, Marcuello A, Casajús JA, et al. Human mitochondrial haplogroup H: the highest VO2max consumer - is it a paradox? Mitochondrion 2010;10:102-7.